Extreme Vision (06636) will be holding an initial public offering from March 20 to March 25, intending to globally sell 12.48 million H shares. It will bring in China Huarong International Holdings and GKI as cornerstone investors.

Extreme Vision (06636) will be recruiting from March 20, 2026 to March 25, 2026. Intends to globally sell 12.48 million H shares, with approximately 5% for public sale in Hong Kong and approximately 95% for international sale. The offer price is 40 Hong Kong dollars per share, with 50 H shares per board lot. It is expected that H shares will begin trading on the Hong Kong Stock Exchange on March 30, 2026 (Monday) at 9:00 am. The group is a Chinese AI computer vision solutions provider, offering end-to-end enterprise-level solutions covering development, deployment, and management for businesses across industries. The group also provides commercially viable large-scale model solutions and has successfully expanded its capabilities in empowering digital transformation for enterprises. According to Frost & Sullivan data, based on revenue in 2024, the group ranks eighth in the emerging computer vision solutions market in China. The group has entered cornerstone investment agreements with Government and International Capital, GKI (together referred to as cornerstone investors). Under these agreements, the cornerstone investors have agreed to subscribe for a certain number of offer shares at the offer price (rounded down to the nearest integer multiple of 50 H shares per board lot), totaling 47.20 million Hong Kong dollars (excluding underwriting commissions, SFC transaction levy, HKEX trading fee) (cornerstone investment). Based on an offer price of 40.0 Hong Kong dollars, the total number of offer shares to be subscribed by cornerstone investors will be 1.18 million offer shares. Estimated proceeds net of underwriting commissions and other estimated expenses from the global offering, based on an offer price of 40.0 Hong Kong dollars per H share, is approximately 434 million Hong Kong dollars. The group plans to use the net proceeds from the global offering to enhance its capital base to support continued business growth. Specifically, around 60.0% of the net proceeds are expected to be used to strengthen the group's research and development capabilities, approximately 30.0% for enhancing the group's commercialization capabilities, and around 10.0% for working capital and general corporate purposes. The group achieved rapid growth in the previous reporting period. The group's revenue increased from 102 million RMB in 2022 to 257 million RMB in 2024. The group's revenue for the nine months ended September 30, 2025, increased from 79.40 million RMB to 136 million RMB. The group's adjusted annual loss (non-International Financial Reporting Standards) decreased from 52.90 million RMB in 2022 to 4.43 million RMB in 2023 and turned positive in 2024, with an adjusted annual profit of 20.50 million RMB. For the nine months ended September 30, 2025, the group recorded an adjusted loss of 11.90 million RMB.